Published On May 3, 2024
Amgen (AMGN) sales are higher after early results from a study of an obesity drug. Renita Young discusses this as the Amgen CEO is “very encouraged” by the results of the obesity drug study. Tune in to find out more about the stock market today.
======== Schwab Network ========
Empowering every investor and trader, every market day.
Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe
Download the iOS app - https://apps.apple.com/us/app/schwab-...
Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-...
Watch on Sling - https://watch.sling.com/1/asset/19192...
Watch on Vizio - https://www.vizio.com/en/watchfreeplu...
Watch on DistroTV - https://www.distro.tv/live/schwab-net...
Follow us on X – / schwabnetwork
Follow us on Facebook – / schwabnetwork
Follow us on LinkedIn - / schwab-network
About Schwab Network - https://schwabnetwork.com/about
#investing #trading #finance #stocks #global #equities #markets #stockmarket #stockmarkettoday #amgen